Wyatt Investment Research login

 
Forgot password? Not a Subscriber? - Start Here
 
 
HOMEWEEKLY NEWSLETTERMODEL PORTFOLIOSPECIAL REPORTSVIDEO UPDATESCUSTOMER SERVICE
 
 

Tag - IFLO

 

 
Claire Caldwell

Celldex Therapeutics, US Global Investors and Fauquier Bankshares lead small-cap percentage gainers

Celldex Therapeutics Inc. (Nasdaq:CLDX), US Global Investors Inc. (Nasdaq:GROW) and Fauquier Bankshares Inc. (Nasdaq:FBSS) are among the biggest percentage gainers in Monday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Kirklands Inc. (Nasdaq:KIRK), StealthGas Inc. (Nasdaq:GASS), Amerigon Inc (Nasdaq:ARGN), I-Flow Corp. (Nasdaq:IFLO), CPI Corp. (Nasdaq:CPY) and CPI International Inc. (Nasdaq:CPII).
[ More » ]
Wyatt Research Staff

Orient Express Hotels, Bridge Capital Holdings and Obagi Medical Products among 52-week lows

Orient Express Hotels Ltd. (Nasdaq:OEH), Bridge Capital Holdings (Nasdaq:BBNK) and Obagi Medical Products Inc. (Nasdaq:OMPI) are among the new 52-week lows in Wednesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: I-Flow Corp. (Nasdaq:IFLO), Perry Ellis International Inc. (Nasdaq:PERY), Stoneridge Inc. (Nasdaq:SRI), DealerTrack Holdings Inc. (Nasdaq:TRAK), OneBeacon Insurance Group Ltd. (Nasdaq:OB) and Pharmaxis Depository Receipt (Nasdaq:PXSL).

Here are the new 52-week lows among small caps:


[ More » ]
Will Atkinson

MedQuist, Global Industries and Rackable Systems lead small-cap percentage losers

MedQuist Inc (Nasdaq:MEDQ), Global Industries Ltd (Nasdaq:GLBL) and Rackable Systems Inc (Nasdaq:RACK) are among the biggest percentage losers in Tuesday's trading among companies with market capitalizations under $1 billion.

Also included among the results: Otter Tail Ord Shs (Nasdaq:OTTR), Sun Hydraulics Corp (Nasdaq:SNHY), Fortress Investment Group LLC (Nasdaq:FIG), A Power Energy Generation Systems Ltd (Nasdaq:APWR), Colfax Corp (Nasdaq:CFX) and I-Flow Corp (Nasdaq:IFLO).

Here are the biggest percentage losers among small caps:
[ More » ]
Dianna Heitz

I-Flow falls 14% after swinging to Q2 loss

I-Flow Corporation (Nasdaq:IFLO) swung to a second-quarter loss today, sending shares down 14%. For the second quarter, net loss was $11.4 million, or $0.47 per share, compared with net income of $0.6 million, or $0.03 a share, for the same period a year earlier. The Lake Forest, Calif.-based company said legal and insurance charges dragged the quarterly results into the red.

At 1:21 p.m. ET, shares are at $8.86, down $1.44 from Monday’s close. During the past year, shares have ranged from $8.65 to $20.86. In today’s trading, volume is more than double the average number of shares.

[ More » ]
Alex Alexandrov

Russell 2000 races ahead

The Russell 2000 index is leading the bull market this morning, following news of solid U.S. job growth. At 11:25 a.m. ET the Russell 2000 had added 5.92 points, or 0.70%, to 853.10, above Thursday’s record close. The Dow Jones Industrial Average was up 25.27 points, or 0.19%, to 13,652.91.

Shares of Everlast Worldwide Inc. (Nasdaq: EVST) are higher following news the maker of sporting goods equipment will be acquired by private investor The Hidary Group for $26.50 per share in cash, a 14.5% premium over its closing price on Thursday.
[ More » ]
Wyatt Research Staff

Small-cap percentage gainers

These companies were the biggest percentage gainers at 10:42 ET among companies with market capitalizations under $500 million:
[ More » ]
Mary Ann Azevedo

Friday after hours

Shares of Ariad Pharmaceuticals Inc. (Nasdaq: ARIA) were up $0.08, or by 1.8%, to $4.52 in after-hours trading Friday after the company announced it has filed a counter-claim against Amgen Inc. (Nasdaq: AMGN) and Wyeth (NYSE: WYE) in a patent infringement suit. In April 2006, Amgen filed a lawsuit against Cambridge, Mass.-based Ariad, which develops drugs to treat cancer. Amgen’s goal was to nullify a patent of Ariad’s in order to protect its Enbrel arthritis drug. Later in the year, Ariad unsuccessfully sought to have the lawsuit dismissed. Steep legal fees associated with the lawsuit contributed to Ariad posting a nearly $62 million loss during the fiscal year ending Dec. 31, compared with a $55.5 million loss in fiscal 2005. Ariad Chairman and CEO Dr. Harvey Berger says the suit illustrates the firm’s “strong belief in the validity and enforceability of” its patent.
[ More » ]